In the realm of diabetes management, two innovative medications have emerged as frontrunners: tirzepatide and semaglutide. Both drugs act on specific receptors within the body to control blood sugar levels, offering promising results for individuals with type 2 diabetes. However, these medications exhibit significant differences in their mechanisms